Prestige Consumer Healthcare Inc. (PBH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PBH Revenue Growth
Revenue Breakdown (FY 2025)
PBH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
PBH Revenue Analysis (2014–2025)
As of May 8, 2026, Prestige Consumer Healthcare Inc. (PBH) generated trailing twelve-month (TTM) revenue of $1.10 billion, reflecting slight decline in growth of -2.4% year-over-year. The most recent quarter (Q3 2026) recorded $283.4 million in revenue, up 3.4% sequentially.
Looking at the longer-term picture, PBH's 5-year compound annual growth rate (CAGR) stands at +3.4%, indicating moderate growth over time. The company achieved its highest annual revenue of $1.14 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows PBH's business is primarily driven by Gastrointestinal (22%), Women's Health (21%), and Eye and Ear Care (16%).
When compared to Healthcare sector peers including SPB (-6.3% YoY), CHD (+2.2% YoY), and ENR (+2.7% YoY), PBH has underperformed the peer group in terms of revenue growth. Compare PBH vs SPB →
PBH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PBHCurrent | $1.1B | -2.4% | +3.4% | 29.6% | |
 SPB | $2.8B | -6.3% | +1.4% | 4.4% | |
 CHD | $6.2B | +2.2% | +4.8% | 17.4% | |
 ENR | $3.0B | +2.7% | +1.5% | 17.8% | |
 PRGO | $4.3B | -3.6% | +0.8% | 8.1% | |
 COTY | $5.9B | -3.6% | +4.5% | 4.1% |
PBH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.14B | +1.1% | $634.5M | 55.8% | $336.8M | 29.6% |
| 2024 | $1.13B | -0.2% | $624.4M | 55.5% | $342.4M | 30.4% |
| 2023 | $1.13B | +3.8% | $625.3M | 55.4% | $-22,415,000 | -2.0% |
| 2022 | $1.09B | +15.2% | $620.6M | 57.1% | $329.9M | 30.4% |
| 2021 | $943.4M | -2.0% | $547.5M | 58.0% | $297.4M | 31.5% |
| 2020 | $963.0M | -1.3% | $552.2M | 57.3% | $291.2M | 30.2% |
| 2019 | $975.8M | -6.3% | $555.6M | 56.9% | $67.5M | 6.9% |
| 2018 | $1.04B | +18.0% | $576.5M | 55.4% | $215.9M | 20.7% |
| 2017 | $882.1M | +9.4% | $500.3M | 56.7% | $205.6M | 23.3% |
| 2016 | $806.2M | +12.8% | $467.2M | 57.9% | $260.3M | 32.3% |
See PBH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PBH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PBH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPBH — Frequently Asked Questions
Quick answers to the most common questions about buying PBH stock.
Is PBH's revenue growth accelerating or slowing?
PBH revenue growth slowed to -2.4%, below the 5-year CAGR of +3.4%. TTM revenue is $1.1B. The deceleration marks a shift from historical growth rates.
What is PBH's long-term revenue growth rate?
Prestige Consumer Healthcare Inc.'s 5-year revenue CAGR of +3.4% reflects the variable expansion pattern. Current YoY growth of -2.4% is near this long-term average.
How is PBH's revenue distributed by segment?
PBH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.